Leavell Investment Management, Inc. Novartis Ag Transaction History

Leavell Investment Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 16, 2020	SELL	$70.67 - $99.01 $225,366 - $315,742	-3,189 Closed	0 $0
Q4 2019 Jan 22, 2020	BUY	$84.35 - $95.37 $4,639 - $5,245	55 Added 1.75%	3,189 $302,000
Q3 2019 Oct 28, 2019	BUY	$85.54 - $94.26 $10,179 - $11,216	119 Added 3.95%	3,134 $272,000
Q4 2018 Jan 24, 2019	SELL	$73.66 - $82.02 $14,732 - $16,404	-200 Reduced 6.22%	3,015 $259,000
Q3 2018 Oct 22, 2018	SELL	$66.94 - $77.43 $8,032 - $9,291	-120 Reduced 3.6%	3,215 $277,000
Q1 2018 Apr 25, 2018	SELL	$70.39 - $84.15 $33,435 - $39,971	-475 Reduced 12.47%	3,335 $281,000
Q3 2017 Oct 25, 2017	BUY	$74.14 - $77.27 $282,473 - $294,398	3,810	3,810 $327,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Leavell Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Leavell Investment Management, Inc. with notifications on news.